The complement system: a gateway to gene-environment interactions in schizophrenia pathogenesis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28761078)

Published in Mol Psychiatry on August 01, 2017

Authors

V L Nimgaonkar1,2, K M Prasad1, K V Chowdari1, E G Severance3, R H Yolken3

Author Affiliations

1: Department of Psychiatry, University of Pittsburgh, School of Medicine, Pittsburgh, PA, USA.
2: Department of Human Genetics, University of Pittsburgh, Graduate School of Public Health, Pittsburgh, PA, USA.
3: Stanley Division of Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Articles cited by this

(truncated to the top 100)

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26

Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10

Biological insights from 108 schizophrenia-associated genetic loci. Nature (2014) 16.13

Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol (1997) 9.09

The classical complement cascade mediates CNS synapse elimination. Cell (2007) 9.06

Synaptic density in human frontal cortex - developmental changes and effects of aging. Brain Res (1979) 6.68

Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med (2007) 6.47

Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron (2012) 5.84

The complement system in regulation of adaptive immunity. Nat Immunol (2004) 4.58

Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res (1984) 4.28

Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet (2007) 4.07

A polygenic theory of schizophrenia. Proc Natl Acad Sci U S A (1967) 4.03

Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol (1996) 3.98

Schizophrenia risk from complex variation of complement component 4. Nature (2016) 3.84

Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc Natl Acad Sci U S A (2011) 2.85

Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex (1994) 2.68

Dendritic spine dynamics. Annu Rev Physiol (2009) 2.66

Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry (1988) 2.62

Evolution of the lectin-complement pathway and its role in innate immunity. Nat Rev Immunol (2002) 2.51

High-potency cannabis and the risk of psychosis. Br J Psychiatry (2009) 2.41

Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science (2016) 2.35

Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest (2000) 2.25

Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull (2008) 2.09

Gene-environment interaction: definitions and study designs. Prev Med (1997) 2.04

An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. Cell (1988) 1.90

A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr Bull (2003) 1.88

Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond. Am J Epidemiol (2001) 1.87

Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study. Am J Psychiatry (2011) 1.79

Toxoplasma gondii and other risk factors for schizophrenia: an update. Schizophr Bull (2012) 1.75

Are some cases of psychosis caused by microbial agents? A review of the evidence. Mol Psychiatry (2008) 1.74

Infections of people with complement deficiencies and patients who have undergone splenectomy. Clin Microbiol Rev (2010) 1.70

Toxoplasma infection and later development of schizophrenia in mothers. Am J Psychiatry (2011) 1.69

Childhood-onset schizophrenia: progressive brain changes during adolescence. Biol Psychiatry (1999) 1.66

Exploiting gene-environment independence in family-based case-control studies: increased power for detecting associations, interactions and joint effects. Genet Epidemiol (2005) 1.60

TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat Neurosci (2013) 1.56

Genetic sophistication of human complement components C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex. Am J Hum Genet (2002) 1.47

Gene-environment interaction and covariation in schizophrenia: the role of obstetric complications. Schizophr Bull (2008) 1.44

Complement in the brain. Mol Immunol (2011) 1.41

Humoral response to herpes simplex virus is complement-dependent. Proc Natl Acad Sci U S A (1999) 1.35

A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci (2013) 1.35

Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease. J Exp Med (2000) 1.33

Complement and viral pathogenesis. Virology (2011) 1.32

Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias. Int J Epidemiol (2004) 1.29

Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities, and body mass index. J Immunol (2003) 1.24

Enterovirus infections of the central nervous system. Virology (2011) 1.24

Genetic, structural and functional diversities of human complement components C4A and C4B and their mouse homologues, Slp and C4. Int Immunopharmacol (2001) 1.23

Alternative complement pathway deregulation is correlated with dengue severity. PLoS One (2009) 1.20

Genome-wide study of association and interaction with maternal cytomegalovirus infection suggests new schizophrenia loci. Mol Psychiatry (2013) 1.16

The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology (2011) 1.16

The intricate role of complement component C4 in human systemic lupus erythematosus. Curr Dir Autoimmun (2004) 1.15

Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs. Psychiatry Res (1997) 1.13

Kynurenines in CNS disease: regulation by inflammatory cytokines. Front Neurosci (2014) 1.13

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull (2014) 1.10

Determining the one, two, three, or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding C4A or C4B proteins. Am J Hum Genet (2002) 1.09

Complement and autoimmunity. Immunol Res (2013) 1.04

Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03

Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell (2016) 1.02

Role of complement anaphylatoxin receptors (C3aR, C5aR) in the development of the rat cerebellum. Mol Immunol (2008) 1.02

The complement system in schizophrenia. Drug News Perspect (2008) 1.02

Interaction between BDNF Val66Met and childhood trauma on adult's violent suicide attempt. Genes Brain Behav (2007) 1.02

Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol (1999) 1.02

Where GWAS and epidemiology meet: opportunities for the simultaneous study of genetic and environmental risk factors in schizophrenia. Schizophr Bull (2013) 1.01

The complement system in central nervous system diseases. Autoimmunity (2006) 1.00

Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci (2016) 1.00

Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J Virol (2002) 1.00

Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia. Schizophr Bull (2012) 0.98

Molecular genetic gene-environment studies using candidate genes in schizophrenia: a systematic review. Schizophr Res (2013) 0.97

Assessment of complement C4 gene copy number using the paralog ratio test. Hum Mutat (2010) 0.97

Schizophrenia and rheumatoid arthritis: a review. Schizophr Res (1992) 0.97

Prenatal nutrition, epigenetics and schizophrenia risk: can we test causal effects? Epigenomics (2012) 0.97

Primitive complement system of invertebrates. Immunol Rev (2004) 0.96

Toxoplasma gondii: mechanism of resistance to complement-mediated killing. J Immunol (1989) 0.96

Herpes and pox viral complement control proteins: 'the mask of self'. Trends Immunol (2003) 0.94

Association study of IL10, IL1beta, and IL1RN and schizophrenia using tag SNPs from a comprehensive database: suggestive association with rs16944 at IL1beta. Schizophr Res (2006) 0.93

Genetic basis of human complement C4A deficiency. Detection of a point mutation leading to nonexpression. J Clin Invest (1993) 0.92

Increased complement classical and mannan-binding lectin pathway activities in schizophrenia. Neurosci Lett (2006) 0.92

Classical pathway complement activity in schizophrenia. Neurosci Lett (2005) 0.92

Complement C1q formation of immune complexes with milk caseins and wheat glutens in schizophrenia. Neurobiol Dis (2012) 0.92

Infection and inflammation in schizophrenia and bipolar disorder: a genome wide study for interactions with genetic variation. PLoS One (2015) 0.91

Molecules Great and Small: The Complement System. Clin J Am Soc Nephrol (2015) 0.91

Mouse models of gene-environment interactions in schizophrenia. Neurobiol Dis (2013) 0.90

A complement-microglial axis drives synapse loss during virus-induced memory impairment. Nature (2016) 0.90

Are exposure to cytomegalovirus and genetic variation on chromosome 6p joint risk factors for schizophrenia? Ann Med (2007) 0.87

Developmental neurobiology. Death of a synapse. Nature (1994) 0.87

Complement C4B protein in schizophrenia. World J Biol Psychiatry (2008) 0.87

Obstetric complications as risk factors for schizophrenia spectrum psychoses in offspring of mothers with psychotic disorder. Schizophr Bull (2012) 0.86

Case-only genome-wide interaction study of disease risk, prognosis and treatment. Genet Epidemiol (2010) 0.85

A survey of serum antibodies to eight common viruses in psychiatric patients. Br J Psychiatry (1985) 0.85

Association between copy number variation of complement component C4 and Graves' disease. J Biomed Sci (2011) 0.84

The lectin pathway of complement and rheumatic heart disease. Front Pediatr (2015) 0.84

Maternal complement C1q and increased odds for psychosis in adult offspring. Schizophr Res (2014) 0.84

Neuroscience. How many cell types does it take to wire a brain? Science (2011) 0.83

Evolution of the complement system. Subcell Biochem (2014) 0.83

Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis. Arthritis Rheum (2013) 0.83

Modern complement analysis. Clin Diagn Lab Immunol (2003) 0.83

Genetic risk for schizophrenia, obstetric complications, and adolescent school outcome: evidence for gene-environment interaction. Schizophr Bull (2012) 0.82

Investigation of complement C4B deficiency in schizophrenia. Hum Hered (1997) 0.81

Experimental Toxoplasma gondii infection in mice: the role of the fifth component of complement. Proc Soc Exp Biol Med (1975) 0.81

Sex-limited protein: in vitro and in vivo functions. Clin Exp Immunol (1999) 0.80

Candidate genes and their interactions with other genetic/environmental risk factors in the etiology of schizophrenia. Brain Res Bull (2009) 0.80